You are in the accessibility menu

Please use this identifier to cite or link to this item: http://acervodigital.unesp.br/handle/11449/117454
Title: 
Nanotechnology-based drug delivery systems for treatment of oral cancer: a review
Author(s): 
Institution: 
Universidade Estadual Paulista (UNESP)
ISSN: 
1178-2013
Sponsorship: 
  • Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
  • PADC/FCF-UNESP (Araraquara, Brazil)
Abstract: 
Oral cancer (oral cavity and oropharynx) is a common and aggressive cancer that invades local tissue, can cause metastasis, and has a high mortality rate. Conventional treatment strategies, such as surgery and chemoradiotherapy, have improved over the past few decades; however, they remain far from optimal. Currently, cancer research is focused on improving cancer diagnosis and treatment methods (oral cavity and oropharynx) nanotechnology, which involves the design, characterization, production, and application of nanoscale drug delivery systems. In medicine, nanotechnologies, such as polymeric nanoparticles, solid lipid nanoparticles, nanostructured lipid carriers, gold nanoparticles, hydrogels, cyclodextrin complexes, and liquid crystals, are promising tools for diagnostic probes and therapeutic devices. The objective of this study is to present a systematic review of nanotechnology-based drug delivery systems for oral cancers.
Issue Date: 
1-Jan-2014
Citation: 
International Journal Of Nanomedicine. Albany: Dove Medical Press Ltd, v. 9, p. 3719-3735, 2014.
Time Duration: 
3719-3735
Publisher: 
Dove Medical Press Ltd
Keywords: 
  • targeted delivery
  • oral squamous cell carcinoma
  • oral cancer treatment
Source: 
http://dx.doi.org/10.2147/IJN.S61670
URI: 
Access Rights: 
Acesso aberto
Type: 
outro
Source:
http://repositorio.unesp.br/handle/11449/117454
Appears in Collections:Artigos, TCCs, Teses e Dissertações da Unesp

There are no files associated with this item.
 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.